BBLG.US Bone Biologics Corp

Healthcare Health Care Equipment & Supplies USA Stocks
0.3252 USD
Close of Nov 13, 2026
0.3150 2.39
Market cap
USD 1.10M
P/E
-
P/B
0.23x
ROE
-48.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is BBLG.US undervalued?

Graham number

The Graham number of Bone Biologics Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Bone Biologics Corp fundamental analysis

No fundamental analysis for Bone Biologics Corp yet.

Bone Biologics Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Bone Biologics Corp

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications.…

Full company profile